Merz Pharma Announces Launch Of Denzapine As First Available Generic For Treatment-Resistant Schizophrenia
Today Merz Pharma entered the Irish Healthcare market with Denzapine, the first generic form of clozapine available in Ireland. Denzapine is an atypical antipsychotic agent used in treatment-resistant schizophrenia (TRS) which has been available to prescribe in the UK since February 2004. Denzapine is available in four tablet strengths (25mg, 50mg, 100mg, and 200mg) and as an oral suspension (50mg/ml). As Denzapine must be dispensed under strict medical supervision the web-based Denzapine Monitoring System (DMS) is provided. This allows Healthcare Professionals and treatment teams to securely access patients' blood monitoring and dispensing history and is supported by a team of fully trained staff including an on-call Consultant Haematologist.
If your child faces any problem in learning, you may doubt "does my child have ADHD"? However, you are not the only parent who is asking this question. Many parents ask this question, when their child act without thinking, inattentive or hyperactive. It is therefore worth to understand the symptoms of ADHD. Diagnosing the disorder in the early stage can help the child to lead a normal life. Symptoms of ADHD: The common symptoms of ADHD are inattentiveness, excessive talking, difficulty in remaining seated, forgetfulness in regular activities, avoiding tasks that require mental effort and difficulty in playing calmly. If you recognize any of the symptoms and want to confirm your question "does my child have ADHD", you can make use of the ADHD checklists available online.
ADHD is a behavioral disorder that affects 8 to 10% of school age children. ADHD children experience several problems like poor academic performance, poor relationship with parents, siblings and peers and inattentiveness. If left untreated, ADHD can cause adverse effects. Getting more information on ADHD can help to treat the disorder easily. Symptoms of ADHD: ADHD symptoms may be confused with normal kid behavior. However, if the symptoms like impulsiveness, hyperactivity and inattentiveness appear over the course of several months, the parent of the child should seek the help of a mental health care professional. The professional diagnoses the disorder, by gathering information about the child, his behavior and environment.
Attention Deficit Hyperactivity Disorder may affect the learning ability of children. It can be treated with medications. However, prolonged use of medications can cause adverse side effects. There are several ADHD alternative treatments that help to reduce the symptoms without causing any side effects. Nutrition: Nutrition is the most important ADHD alternative treatment. Many studies have proved that essential fatty acid deficiency can aggravate the learning disability problem in children. ADHD children receiving essential fatty acid supplements would show significant improvement in learning and writing than the children receiving medication.
Attention Deficit Hyperactivity Disorder is a condition that affects 8 to 10% of school age children. ADHD children are hyperactive and they have trouble in concentrating. If you have an ADHD child, it is advisable to learn a lot about this disorder. There are numerous ADHD myths that may confuse you a lot. Understanding the facts can help you to travel in the right path and to reduce the problematic symptoms in your child. ADHD myths: Some people believe that ADHD is not a disorder. However, it is not true. ADHD is recognized as a disorder by the American Medical Association and psychiatric and psychological associations. The symptoms of ADHD are often confused with normal child behavior.
Statement Of Mental Health America On Regulations Implementing Wellstone-Domenici Mental Health Parity And Addiction Equity Act
Mental Health America applauds the release of the regulations implementing the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act. We greatly appreciate all the thoughtful work that the staff and leaders of the three agencies charged with implementing this law put into developing these regulations. They clarify a number of key issues that will greatly help to ensure the intent of the parity law- to prohibit discriminatory treatment of mental health and substance use conditions-is fully realized and implemented. These regulations clarify that the Wellstone-Domenici parity law prohibits plans from discriminating against mental health and substance use treatment in application of medical management, prescription formulary design, standards for provider admission into preferred provider network, determination of usual and customary amounts of care, and fail first or step therapy requirements.